A
$ Value
$0
Shares
49,796
Price
$0
Filed
Jun 6
Insider
Name
Kumar Rashmi
Title
—
CIK
0001824720
Roles
Director
Transaction Details
Transaction Date
2025-06-05
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
127,188
Footnotes
Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant.
Filing Info
Kumar Rashmi's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-06-05 | MYGN | A | $0 |
Other Insiders at MYGN (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Verratti Mark
Chief Operating Officer
|
— | — | 2026-04-14 |
|
Haas Kevin Richard
Chief Technology Officer
|
— | — | 2026-02-02 |
|
Muzzey Dale
Chief Scientific Officer
|
— | — | 2026-04-14 |
|
Wheeler Benjamin Richard
Chief Financial Officer
|
— | — | 2026-02-02 |